While the precise cause behind macular degeneration remains unknown, there are factors that increase a person’s risk for developing this eye condition. Some of these factors include advancing age, ...

EB-203 is under clinical development by Eye Bio Korea and currently in Phase II for Wet (Neovascular / Exudative) Macular Degeneration. According to GlobalData, Phase II drugs for Wet (Neovascular / ...

Macular degeneration is an eye disease that affects your central vision. It occurs when the macula, part of your retina, becomes damaged. Let's explore ways to protect your eyes if you have ...

Macular degeneration occurs as cells within the retinal pigment epithelium (RPE) degrade and die. The RPE is a layer of light ...

But eye problems aren't something you should ... The wet form of age-related macular degeneration can start suddenly. You won’t feel pain, but you might notice vision problems.

Purpose To investigate the possible differences in choroidal thickness (CT) between non-neovascular (NNV) and neovascular (NV) age-related macular degeneration (AMD). Methods A retrospective, ...

Leading the way to fight age-related macular degeneration The Wold Family Macular Degeneration Center at OHSU Casey Eye Institute is at the forefront of research, patient care and education for ...

Age-related macular degeneration (ARMD) is the slow deterioration of the cells in the macula ... Two of these are the Visual Acuity test (eye chart) and an Amsler Grid test. The clinical objective in ...